ALLEGAN – Perrigo Company announced Monday that it has acquired Laboratorios Diba, S.A. for approximately $25 million in cash. Based in Guadalajara, Mexico, privately-held Laboratorios Diba is a store brand manufacturer of over-the-counter and prescription pharmaceuticals, including
antibiotics, hormonals and opthalmics. The acquisition is expected to add
nearly $15 million of annual sales.
“Perrigo has been in the Mexican market for more than 65 years and is the leading supplier of prescription and OTC store brand products there. The acquisition of Laboratorios Diba will enable us to market an additional 150 formulas and 50 trademarks into the rapidly growing Mexican store brand market, saving consumers money on their healthcare options,” said Perrigo’s Chairman and CEO Joseph Papa. “This further exemplifies
Perrigo’s commitment to meeting the growing need for quality, affordable
healthcare around the world.”
Perrigo Company is a leading global healthcare supplier that develops,
manufactures and distributes OTC and prescription pharmaceuticals,
nutritional products, active pharmaceutical ingredients (API) and consumer
products. The Company is the world’s largest manufacturer of OTC
pharmaceutical products for the store brand market. The Company’s primary
markets and locations of manufacturing facilities are the United States,
Israel, Mexico and the United Kingdom.
For more information, click on Perrigo.Com
a>>
